论文部分内容阅读
钙阻滞剂心痛定(NF)治疗高血压病的疗效已得到众多报道的肯定,异搏定(VR)作为降压药的价值,1985年西柏林国际专题会议上得到很高的评价,国内未见专题报道,为探求其对国人的疗效及剂量。1986年10月我们设计了VR和NF治疗高血压病的对比观察方案,现把一年多来观察结果报道如下:
The efficacy of calcium blockers nifedipine (NF) in the treatment of hypertension has been affirmed by many reports. The value of verapamil (VR) as an antihypertensive drug was highly appraised at the 1985 West Berlin International Symposium, No special reports, in order to explore its effect on the people and dose. October 1986 we designed the VR and NF treatment of hypertension contrast observation program, now more than a year of observations reported as follows: